Skip to main content

MARTINGALE ASSET MANAGEMENT L P

Position in NBIX — Neurocrine Biosciences Inc

CIK 936944 BOSTON, MA

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$5,404,370
+$5,166,664 QoQ
Shares Held
41,023
+2347.7% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
12 quarters on record
Voting authority Sole 72.45447675694123.ToString("F0")% Shared 0.ToString("F0")% None 27.545523243058774.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MARTINGALE ASSET MANAGEMENT L P holds $47,192,066 across 16 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (11.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
41,023 $5,404,370

All Filings in NBIX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,404,370 41,023
2025-12-31 $237,706 1,676
2025-03-31 $353,477 3,196
2024-12-31 $3,119,707 22,855
2024-09-30 $3,031,553 26,311
2024-06-30 $4,090,312 29,711
2024-03-31 $4,280,622 31,037
2023-12-31 $3,492,561 26,507
2023-09-30 $2,915,775 25,918
2023-06-30 $2,628,329 27,872
2023-03-31 $2,812,296 27,784
2022-12-31 $2,594,595 21,723